新型冠状病毒感染相关生物标记物研究进展

Research progress on biomarkers of coronavirus disease 2019

导出

摘要新型冠状病毒感染(coronavirus disease 2019,COVID-19)自2019年12月在全球各地出现后,迅速演变为全球重大公共卫生事件。COVID-19具有潜伏期长,人群普遍易感,感染力强,病情严重者可引起死亡。本文就C反应蛋白、白细胞介素-6、降钙素原、γ干扰素诱导蛋白10、血清淀粉样蛋白A、铁蛋白、白细胞分化抗原147、内皮细胞特异分子-1、不对称二甲基精氨酸、正五聚蛋白3等重要标志物在COVID-19检测和治疗中的应用进行综述。

作者赵龙杨国威刘蓓 Zhao Long;Yang Guowei;Liu Bei

机构地区甘肃省兰州大学第一医院血液科甘肃省兰州大学第一医院中医科

出处《国际病毒学杂志》 2023年第6期512-515,共4页 International Journal of Virology

关键词新型冠状病毒感染生物标记物

分类号 R563.1 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献1

1Huijie Bian,Zhao-Hui Zheng,Ding Wei,Aidong Wen,Zheng Zhang,Jian-Qi Lian,Wen-Zhen Kang,Chun-Qiu Hao,Jing Wang,Rong-Hua Xie,Ke Dong,Jie-Lai Xia,Jin-Lin Miao,Wen Kang,Guoquan Li,Di Zhang,Mingru Zhang,Xiu-Xuan Sun,Likun Ding,Kui Zhang,Junfeng Jia,Jin Ding,Zhiqin Li,Yanyan Jia,Lin-Na Liu,Zhe Zhang,Zhao-Wei Gao,Hong Du,Na Yao,Qing Wang,Ke Wang,Jie-Jie Geng,Bin Wang,Ting Guo,Ruo Chen,Yu-Meng Zhu,Li-Juan Wang,Qian He,Rui-Rui Yao,Ying Shi,Xiang-Min Yang,Jian-Sheng Zhou,Yi-Nan Ma,Ya-Tao Wang,Xue Liang,Fei Huo,Zhe Wang,Yang Zhang,Xu Yang,Ye Zhang,Lu-Hua Gao,Ling Wang,Xiao-Chun Chen,Hao Tang,Shuang-Shuang Liu,Qing-Yi Wang,Zhi-Nan Chen,Ping Zhu.Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial[J].Signal Transduction and Targeted Therapy,2021,6(6):1845-1855. 被引量：4

二级参考文献5

1Kun Zhang,Yu Zhao,Zheng Zhang,Mengyao Zhang,Xiaodong Wu,Huijie Bian,Ping Zhu,Zhinan Chen.Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum[J].Acta Pharmaceutica Sinica B,2020,10(9):1680-1693. 被引量：1
2Yingxia Liu,Yang Yang,Cong Zhang,Fengming Huang,Fuxiang Wang,Jing Yuan,Zhaoqin Wang,Jinxiu Li,Jianming Li,Cheng Feng,Zheng Zhang,Lifei Wang,Ling Peng,Li Chen,Yuhao Qin,Dandan Zhao,Shuguang Tan,Lu Yin,Jun Xu,Congzhao Zhou,Chengyu Jiang,Lei Liu.Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury[J].Science China(Life Sciences),2020,63(3):364-374. 被引量：176
3吕新军(编译),Huang C,Wang Y,Li X.武汉市新型冠状病毒感染患者的临床特征[J].中华实验和临床病毒学杂志,2020,34(1):42-42. 被引量：2547
4Ke Wang,Wei Chen,Zheng Zhang,Yongqiang Deng,Jian-Qi Lian,Peng Du,Ding Wei,Yang Zhang,Xiu-Xuan Sun,Li Gong,Xu Yang,Lei He,Lei Zhang,Zhiwei Yang,Jie-Jie Geng,Ruo Chen,Hai Zhang,Bin Wang,Yu-Meng Zhu,Gang Nan,Jian-Li Jiang,Ling Li,Jiao Wu,Peng Lin,Wan Huang,Liangzhi Xie,Zhao-Hui Zheng,Kui Zhang,Jin-Lin Miao,Hong-Yong Cui,Min Huang,Jun Zhang,Ling Fu,Xiang-Min Yang,Zhongpeng Zhao,Shihui Sun,Hongjing Gu,Zhe Wang,Chun-Fu Wang,Yacheng Lu,Ying-Ying Liu,Qing-Yi Wang,Huijie Bian,Ping Zhu,Zhi-Nan Chen.CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells[J].Signal Transduction and Targeted Therapy,2020,5(1):162-171. 被引量：43
5Li Tan,Qi Wang,Duanyang Zhang,Jinya Ding,Qianchuan Huang,Yi-Quan Tang,Qiongshu Wang,Hongming Miao.Lymphopenia predicts disease severity of COVID-19:a descriptive and predictive study[J].Signal Transduction and Targeted Therapy,2020,5(1):2129-2131. 被引量：35

共引文献3

1文爱东,刘美佑,樊婷婷,丁莉坤,任丹君.加强临床监测研究确保生物创新药的安全使用[J].药物不良反应杂志,2021,23(10):505-507.
2Jiejie Geng,Liang Chen,Yufeng Yuan,Ke Wang,Youchun Wang,Chuan Qin,Guizhen Wu,Ruo Chen,Zheng Zhang,Ding Wei,Peng Du,Jun Zhang,Peng Lin,Kui Zhang,Yongqiang Deng,Ke Xu,Jiangning Liu,Xiuxuan Sun,Ting Guo,Xu Yang,Jiao Wu,Jianli Jiang,Ling Li,Kun Zhang,Zhe Wang,Jing Zhang,Qingguo Yan,Hua Zhu,Zhaohui Zheng,Jinlin Miao,Xianghui Fu,Fengfan Yang,Xiaochun Chen,Hao Tang,Yang Zhang,Ying Shi,Yumeng Zhu,Zhuo Pei,Fei Huo,Xue Liang,Yatao Wang,Qingyi Wang,Wen Xie,Yirong Li,Mingyan Shi,Huijie Bian,Ping Zhu,Zhi-Nan Chen.CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta,alpha,beta,and gamma[J].Signal Transduction and Targeted Therapy,2021,6(10):3142-3154. 被引量：8
3武昕,于汉杰,包晓娟,王雨姿,李铮.新型冠状病毒抗体和小分子抑制剂的研究现状[J].生物化学与生物物理进展,2024,51(4):754-771.

1冯二香,许爱国,刘剑.血清ADMA和NOX4与慢性阻塞性肺疾病患者并发肺动脉高压的关系[J].实验与检验医学,2023,41(5):651-655.
2王晓玲,张立杰,肖四海,宋巧凤,周文华,王麟,夏英杰.慢性心力衰竭患者循环Endocan水平与心功能相关性及其对心血管主要终点事件的影响[J].中国循证心血管医学杂志,2023,15(3):302-305. 被引量：3
3周航.甲状腺癌组织中趋化因子受体7、白细胞分化抗原147、胰岛素样生长因子-1受体表达的相关性分析[J].现代诊断与治疗,2023,34(15):2277-2279.
4池跃朋,梁亚充,李晓倩,王智慧,王玉红,董雅坤,牛波.内科胸腔镜联合胸腔积液BIRC5、IP-10对结核性胸腔积液及恶性胸腔积液的鉴别价值研究[J].中华保健医学杂志,2023,25(2):170-174. 被引量：3
5赵丹华,徐海龙,李民强,刘红,马海芳,蔡安盛.盐酸地尔硫䓬联合心宝丸治疗冠状动脉微血管疾病的临床研究[J].世界临床药物,2023,44(9):971-975.
6张雪芳,邢英瀛,程曼,张小林.CD147、ESM-1、sdLDL-C与ACI患者颈动脉斑块性质及狭窄程度的关联性[J].医药论坛杂志,2023,44(9):58-62. 被引量：1
7李翠乔,刘宇飞,田淋蓥,段先佳,何萍,王本余,王国卫.温脾活血汤联合2HRZE/4HR方案治疗结核性胸膜炎的临床疗效与机制研究[J].中国医院用药评价与分析,2023,23(6):669-672. 被引量：1
8杨文文,代景娜,窦晨辉,张士金.通心阳方加减联合耳穴压豆治疗冠心病稳定型心绞痛临床观察[J].山西中医,2023,39(7):11-13.
9倪秀.媒体融合背景下短视频新闻的发展路径创新[J].传播力研究,2024,8(5):76-78.
10李源昌,王鹏.伊伐布雷定联合沙库巴曲缬沙坦对慢性充血性心力衰竭的影响[J].中外医学研究,2023,21(33):14-18.

国际病毒学杂志

2023年第6期

浏览历史

内容加载中请稍等...

新型冠状病毒感染相关生物标记物研究进展

参考文献1

二级参考文献5

共引文献3

相关作者

相关机构

相关主题

浏览历史